ALZNVSSLS• 28 Days (Normalized)
ALZN vs SLS (Alzamend Neuro Inc. vs SELLAS Life Sciences Group Inc.)
Showing Closing Date Range from Aug, 17 to Sep, 14, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
ALZN Performance $1.75
+10.76%
Alzamend Neuro Inc.
Normalized Baseline0.00%
SLS Performance $12.07
-7.15%
SELLAS Life Sciences Group Inc.
Normalized Baseline0.00%
Alpha Spread Margin ALZN LEADS
+17.91%
ALZN outperforming by 17.91%
ALZNSLS
Spread Trajectory28 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
ALZN SLS
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(20 dates)
| Date | ALZN Price | ALZN Gain (%) | SLS Price | SLS Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 14, 2026 | $1.75 | +10.76% | $12.07 | -7.15% | +17.91% |
| Sep 11, 2026 | $1.72 | +8.86% | $11.55 | -11.15% | +20.01% |
| Sep 10, 2026 | $1.70 | +7.59% | $13.49 | +3.77% | +3.82% |
| Sep 09, 2026 | $1.68 | +6.33% | $13.95 | +7.31% | -0.98% |
| Sep 08, 2026 | $1.68 | +6.33% | $13.96 | +7.38% | -1.05% |
| Sep 04, 2026 | $1.66 | +5.06% | $13.86 | +6.62% | -1.56% |
| Sep 03, 2026 | $1.70 | +7.59% | $13.70 | +5.38% | +2.21% |
| Sep 02, 2026 | $1.70 | +7.59% | $14.16 | +8.92% | -1.33% |
| Sep 01, 2026 | $1.64 | +3.61% | $13.22 | +1.69% | +1.92% |
| Aug 31, 2026 | $1.60 | +1.27% | $13.34 | +2.62% | -1.35% |
| Aug 28, 2026 | $1.66 | +5.06% | $13.21 | +1.62% | +3.44% |
| Aug 27, 2026 | $1.67 | +5.38% | $15.21 | +17.00% | -11.62% |
| Aug 26, 2026 | $1.67 | +5.70% | $13.73 | +5.62% | +0.08% |
| Aug 25, 2026 | $1.60 | +1.27% | $14.09 | +8.38% | -7.11% |
| Aug 24, 2026 | $1.55 | -1.90% | $14.33 | +10.23% | -12.13% |
Page 1 of 2